This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Andreas Kuhn
Senior Vice President RNA Biochemistry & Manufacturing at BioNTech RNA Pharmaceuticals GmbH


Andreas Kuhn, Ph.D., has worked in the field of RNA biochemistry and molecular biology for more than twenty-five years. His work on mRNA-based therapeutics began in 2007, and Andreas joined BioNTech RNA Pharmaceuticals GmbH shortly after its founding. His main focus in his current role as Senior Vice President RNA Biochemistry & Manufacturing is expanding proprietary technologies to increase the efficacy of mRNA therapeutics and to optimize GMP-compatible manufacturing processes for RNA. He has co-authored several publications and patents ranging from basic research on RNA to its application as a diagnostic and therapeutic agent.

Agenda Sessions

  • mRNA as a Platform Technology for Rapid Development of Vaccines Against Viral Infections – Covid-19 and Beyond